InfuSystem Holdings (INFU) Share-based Compensation (2010 - 2026)
InfuSystem Holdings (INFU) reported Share-based Compensation of $1.2 million for Q1 2026, up 11.28% on a YoY basis from $1.1 million in Q1 2025, and down 3.07% quarter-over-quarter from $1.3 million in Q4 2025.
InfuSystem Holdings (INFU) Share-based Compensation (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Share-based Compensation for 11 years, with the latest figure at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 11.28% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 0.51% YoY), and the FY2025 full-year result was $4.4 million, down 2.17% from the prior year.
- Share-based Compensation for Q1 2026 stood at $1.2 million, down from $1.3 million in the prior quarter.
- The five-year high for Share-based Compensation was $1.3 million in Q3 2025, with the low at $589000.0 in Q4 2022.
- Historically, Share-based Compensation has averaged $1.1 million across 5 years, with a median of $1.1 million in 2022.
- Annual changes were most pronounced in 2022 — Share-based Compensation sank 59.15% — and 2023, when it surged 116.47%.
- InfuSystem Holdings' Share-based Compensation stood at $589000.0 in 2022, then surged by 116.47% to $1.3 million in 2023, then retreated by 7.14% to $1.2 million in 2024, then gained by 7.43% to $1.3 million in 2025, then dropped by 3.07% to $1.2 million in 2026.
- The last three Share-based Compensation figures came in at $1.2 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 661,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Mar 31, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 998,000.00 |
| Jun 30, 2024 | 998,000.00 |
| Mar 31, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Dec 31, 2023 | 1.28 Mn |